176
Views
5
CrossRef citations to date
0
Altmetric
Review

Kidney biomarkers in tropical infections: an update

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon

References

  • Watts C. Neglected tropical diseases: A DFID perspective. Walson JL, ed. PLoS Negl Trop Dis. 2017;11(4):e0005492.
  • Kamath N, Iyengar A. Infections and the kidney: a tale from the tropics. Pediatr Nephrol. 2018;33(8):1317–1326.
  • World Health Organization. International Programme on Chemical Safety. Biomarkers in risk assessment: validity and validation. Geneva: WHO; 2001. Available from http://www.inchem.org/documents/ehc (Accessed in July 2020).
  • World Health Organization. International Programme on Chemical Safety. Biomarkers and risk assessment: concepts and principles. Vol. 155. Geneva: WHO; 1993. Available from http://www.inchem.org/documents/ehc/ehc/ehc155.htm (Accessed in April 2020).
  • McCullough PA, Bouchard J, Waikar SS, et al. Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the acute dialysis quality initiative (ADQI). Contrib Nephrol. 2013;182:5–12.
  • Elshafie AI, Elghazali G, Rönnelid J, et al. C as a marker of immune complex-associated renal impairment in a sudanese population with visceral leishmaniasis. Am J Trop Med Hyg. 2006;75(5):864–868.
  • Oliveira MJC, Silva GB, Abreu KLS, et al. Risk factors for acute kidney injury in visceral leishmaniasis (Kala-Azar). Am J Trop Med Hyg. 2010;82(3):449–453.
  • Meneses GC, De Francesco Daher E, da Silva Junior GB, et al. Visceral leishmaniasis-associated nephropathy in hospitalised Brazilian patients: new insights based on kidney injury biomarkers. Trop Med Int Heal. 2018;23(10):1046–1057.
  • Oliveira MJC, Silva JGB, Sampaio AM, et al. Short report: preliminary study on tubuloglomerular dysfunction and evidence of renal inflammation in patients with Visceral leishmaniasis. Am J Trop Med Hyg. 2014;91(5):908–911.
  • Grandaliano G, Gesualdo L, Ranieri E, et al. Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: A pathogenetic role in interstitial monocytes recruitment. J Am Soc Nephrol. 1996;7(6):906–913.
  • Rocha PN, Macedo MN, Kobayashi CD, et al. Role of urine neutrophil gelatinase-associated lipocalin in the early diagnosis of amphotericin B-induced acute kidney injury. Antimicrob Agents Chemother. 2015;59(11):6913–6921.
  • Coll E, Botey A, Alvarez L, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000;36(1):29–34.
  • Elnojomi NA, Musa AM, Younis BM, et al. Surrogate markers of subtle renal injury in patients with visceral leishmaniasis. Saudi J Kidney Dis Transpl. 2010;21(5):872–875.
  • World Health Organization. Malaria; 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/malaria (Accessed in July 2020).
  • Mishra SK, Das BS. Malaria and acute kidney injury. Semin Nephrol. 2008;28(4):395–408.
  • Elsheikha HM, Sheashaa HA. Epidemiology, pathophysiology, management and outcome of renal dysfunction associated with plasmodia infection. Parasitol Res. 2007;101(5):1183–1190.
  • Da Silva Junior GB, Pinto JR, Barros EJG, et al. Kidney involvement in malaria: an update. Rev Inst Med Trop Sao Paulo. 2017;59(December2016):1–6.
  • Van Wolfswinkel ME, Koopmans LC, Hesselink DA, et al. Neutrophil gelatinase-associated lipocalin (NGAL) predicts the occurrence of malaria-induced acute kidney injury. Malar J. 2016;15(1):1–8.
  • Hanson J, Hasan MM, Royakkers AA, et al. Laboratory prediction of the requirement for renal replacement in acute falciparum malaria. Malar J. 2011;10(1):217.
  • Plewes K, Royakkers AA, Hanson J, et al. Correlation of biomarkers for parasite burden and immune activation with acute kidney injury in severe falciparum malaria. Malar J. 2014;13(1):1–10.
  • Günther A, Burchard GD, Slevogt H, et al. Renal dysfunction in falciparum - Malaria is detected more often when assessed by serum concentration of cystatin C instead of creatinine. Trop Med Int Heal. 2002;7(11):931–934.
  • Burchard GD, Ehrhardt S, Mockenhaupt FP, et al. Renal dysfunction in children with uncomplicated, Plasmodium falciparum malaria in Tamale, Ghana. Ann Trop Med Parasitol. 2003;97(4):345–350.
  • Conroy AL, Hawkes M, Elphinstone RE, et al. Acute kidney injury is common in pediatric severe malaria and is associated with increased mortality. Open Forum Infect Dis. 2016;3(2):1–9.
  • Punsawad C, Viriyavejakul P. Nuclear factor kappa B in urine sediment: A useful indicator to detect acute kidney injury in Plasmodium falciparum malaria. Malar J. 2014;13:1.
  • World Health Organization. Neglected tropical diseases; 2020. Available from: https://www.who.int/neglected_diseases/zoonoses/infections_more/en/ (Accessed in July 2020).
  • Srisawat N, Praditpornsilpa K, Patarakul K, et al. Neutrophil gelatinase associated lipocalin (NGAL) in leptospirosis acute kidney injury: a multicenter study in Thailand. PLoS One. 2015;10(12):1–14.
  • Gómez RM, Vieira ML, Schattner M, et al. Putative outer membrane proteins of Leptospira interrogans stimulate human umbilical vein endothelial cells (HUVECS) and express during infection. Microb Pathog. 2008;45(56):315–322.
  • Vieira ML, D’Atri LP, Schattner M, et al. A novel leptospiral protein increases ICAM-1 and E-selectin expression in human umbilical vein endothelial cells. FEMS Microbiol Lett. 2007;276(2):172–180.
  • Libório AB, Braz MBM, Seguro AC, et al. Endothelial glycocalyx damage is associated with leptospirosis acute kidney injury. Am J Trop Med Hyg. 2015;92(3):611–616.
  • Chagan-Yasutan H, Chen Y, Lacuesta TL, et al. Urine levels of defensin α1 reflect kidney injury in leptospirosis patients. Int J Mol Sci. 2016;17(10):1–13.
  • Nicolescu M, Andreescu N. May human leptospirosis develop as a chronic infection? Zentralblatt fur Bakteriol Mikrobiol und Hyg - Abt 1 Orig A. 1984;257(4):530.
  • Ganoza CA, Matthias MA, Saito M, et al. Asymptomatic renal colonization of humans in the Peruvian Amazon by Leptospira. PLoS Negl Trop Dis. 2010;4:2.
  • Riefkohl A, Ramírez-Rubio O, Laws RL, et al. Leptospira seropositivity as a risk factor for Mesoamerican nephropathy. Int J Occup Environ Health. 2017;23(1):1–10.
  • Yang HY, Hung CC, Liu SH, et al. Overlooked risk for chronic kidney disease after leptospiral infection: a population-based survey and epidemiological cohort evidence. PLoS Negl Trop Dis. 2015;9(10):1–15.
  • De Francesco Daher E, Zanetta DMT, Abdulkader RCRM. Pattern of renal function recovery after leptospirosis acute renal failure. Nephron Clin Pract. 2004;98(1):c8–c14.
  • el-Sherif AK, Befus D. Predominance of IgA deposits in glomeruli of Schistosoma mansoni infected mice. Clin Exp Immunol. 1988;71(1):39–44.
  • Martinelli R, Rocha H. Nefrologia clínica: envolvimento glomerular na esquistossomose mansônica. J Bras Nefrol. 1996;18(3):279–282.
  • Barsoum R. The changing face of schistosomal glomerulopathy. Kidney Int. 2004;66(6):2472–2484.
  • Abensur H, Nussenzveig I, Saldanha LB, et al. Nephrotic syndrome associated with hepatointestinal schistosomiasis. Rev Inst Med Trop Sao Paulo. 1992;34(4):273–276.
  • Rodrigues VL, Otoni A, Voieta I, et al. Glomerulonephritis in schistosomiasis mansoni: a time to reappraise. Rev Soc Bras Med Trop. 2010;43(6):638–642.
  • Duarte DB, Vanderlei LA, De Azevêdo Bispo RK, et al. Renal function in hepatosplenic schistosomiasis - an assessment of renal tubular disorders. PLoS One. 2014;9(12):1–15.
  • Hanemann ALP, Libório AB, Daher EF, et al. Monocyte chemotactic protein-1 (MCP-1) in patients with chronic schistosomiasis mansoni: evidences of subclinical renal inflammation. PLoS One. 2013;8(11):8–12.
  • MITSUDA K, OGAWA M. A study of one hundred and fifty autopsies on cases of leprosy. Int J Lepr. 1937;5:53–60.
  • Meneses GC, Libório AB, de Daher EF, et al. Urinary monocyte chemotactic protein-1 (MCP-1) in leprosy patients: increased risk for kidney damage. BMC Infect Dis. 2014;14(1):1–5.
  • Kirsztajn GM, Nishida SK, Silva MS, et al. Renal abnormalities in leprosy. Nephron. 1993;65(3):381–384.
  • Oliveira RA, Silva GB, Souza CJ, et al. Evaluation of renal function in leprosy: A study of 59 consecutive patients. Nephrol Dial Transplant. 2008;23(1):256–262.
  • Polito MG, Moreira SR, Nishida SK, et al. It is time to review concepts on renal involvement in leprosy: pre- and post-treatment evaluation of 189 patients. Ren Fail. 2015;37(7):1171–1174.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.